Rhumbline Advisers Buys 3,104 Shares of Equifax, Inc. $EFX

Rhumbline Advisers grew its stake in Equifax, Inc. (NYSE:EFX) by 1.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 240,246 shares of the credit services provider’s stock after purchasing an additional 3,104 shares during the quarter. Rhumbline Advisers’ holdings in Equifax were worth $61,630,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently modified their holdings of EFX. Country Trust Bank bought a new stake in shares of Equifax during the 2nd quarter valued at about $26,000. Caldwell Trust Co purchased a new stake in Equifax in the second quarter worth about $33,000. Spire Wealth Management lifted its holdings in Equifax by 82.9% in the third quarter. Spire Wealth Management now owns 128 shares of the credit services provider’s stock worth $33,000 after buying an additional 58 shares during the period. State of Wyoming bought a new stake in Equifax during the 2nd quarter valued at approximately $34,000. Finally, NewSquare Capital LLC grew its holdings in shares of Equifax by 98.5% during the 2nd quarter. NewSquare Capital LLC now owns 135 shares of the credit services provider’s stock worth $35,000 after acquiring an additional 67 shares during the period. 96.20% of the stock is owned by hedge funds and other institutional investors.

Equifax Price Performance

EFX opened at $188.30 on Friday. The firm has a market cap of $23.05 billion, a PE ratio of 35.39, a P/E/G ratio of 1.74 and a beta of 1.55. The stock has a 50-day moving average price of $211.77 and a 200-day moving average price of $226.26. Equifax, Inc. has a 1 year low of $166.02 and a 1 year high of $281.03. The company has a debt-to-equity ratio of 0.88, a current ratio of 0.60 and a quick ratio of 0.74.

Equifax (NYSE:EFX) last announced its quarterly earnings data on Wednesday, February 4th. The credit services provider reported $2.09 EPS for the quarter, beating the consensus estimate of $2.05 by $0.04. The company had revenue of $1.55 billion for the quarter, compared to the consensus estimate of $1.53 billion. Equifax had a net margin of 10.87% and a return on equity of 19.27%. Equifax’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the prior year, the firm posted $2.12 EPS. Equifax has set its FY 2026 guidance at 8.300-8.700 EPS and its Q1 2026 guidance at 1.630-1.730 EPS. Sell-side analysts predict that Equifax, Inc. will post 7.58 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Equifax news, CEO Mark W. Begor sold 37,791 shares of the stock in a transaction on Tuesday, February 10th. The stock was sold at an average price of $201.89, for a total transaction of $7,629,624.99. Following the sale, the chief executive officer directly owned 230,506 shares in the company, valued at approximately $46,536,856.34. This trade represents a 14.09% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Jamil Farshchi sold 1,167 shares of Equifax stock in a transaction on Wednesday, February 11th. The stock was sold at an average price of $199.87, for a total value of $233,248.29. Following the completion of the sale, the executive vice president directly owned 39,869 shares of the company’s stock, valued at approximately $7,968,617.03. The trade was a 2.84% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 45,171 shares of company stock worth $9,079,441. Corporate insiders own 1.40% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on EFX. Stifel Nicolaus lowered their target price on Equifax from $253.00 to $235.00 and set a “buy” rating for the company in a research note on Thursday, February 5th. JPMorgan Chase & Co. lowered their price objective on Equifax from $260.00 to $230.00 and set an “overweight” rating for the company in a research report on Thursday, February 5th. Needham & Company LLC dropped their target price on shares of Equifax from $295.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, February 5th. Barclays reduced their target price on shares of Equifax from $240.00 to $215.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 5th. Finally, Oppenheimer lowered their price target on shares of Equifax from $271.00 to $266.00 and set an “outperform” rating for the company in a research report on Monday, January 12th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $240.33.

Equifax Company Profile

Equifax Inc (NYSE: EFX) is a global data, analytics and technology company that specializes in consumer and commercial credit reporting, decisioning tools and identity solutions. Headquartered in Atlanta, Georgia, Equifax is one of the three major consumer credit reporting agencies in the United States and provides credit information and related services to lenders, employers, governments and consumers worldwide.

The company’s offerings include consumer credit reports and scores, credit monitoring and identity protection services, and a range of business-oriented products for risk management, fraud detection and compliance.